Insights

CF Leadership Global leader in nebulizer devices for cystic fibrosis, PARI offers a trusted platform ideal for targeting cystic fibrosis centers with device upgrades, consumables, and service contracts.

Global Footprint A multi site presence in Germany and an international distribution network enables rapid expansion into hospitals, clinics, and home care markets across regions with existing partners.

Full Portfolio PARI's comprehensive inhalation portfolio supports diagnosis, treatment, and monitoring, creating cross selling opportunities for devices, saline solutions, and related care services.

Pharma Partnerships PARI Pharma and eFlow technology offer potential collaborations with pharmaceutical companies for inhaled therapies, licensing, or contract manufacturing to broaden adoption of PARI devices.

Trusted Network Strong reputation among physicians, pharmacists, and patients supports winning tenders and distribution deals with respiratory care networks and medical distributors.

Similar companies to PARI

PARI Tech Stack

PARI uses 8 technology products and services including Adobe Illustrator, GitHub, Pimcore, and more. Explore PARI's tech stack below.

Adobe Illustrator
Cad & Graphics
GitHub
Communication And Collaboration
Pimcore
Content Management System
Microsoft Outlook
Email
jQuery
Javascript Libraries
Microsoft Office
Office Suites
Linux
Programming Languages
Bootstrap
UI Frameworks

Media & News

PARI's Email Address Formats

PARI uses at least 2 format(s):

PARI Email Formats	Example	Percentage
First.Last@pari.com	John.Doe@pari.com	87%
FLast@pari.com	JDoe@pari.com	10%
First@pari.com	John@pari.com	1%
FirstL@pari.com	JohnD@pari.com	2%
F.Last@pari.de	J.Doe@pari.de	88%
F_Last@pari.de	J_Doe@pari.de	7%
First.Last@pari.de	John.Doe@pari.de	5%

Frequently Asked Questions

Where is PARI's headquarters located?

PARI's main headquarters is located at 3 Moosstrasse Starnberg, Bavaria 82319 Germany. The company has employees across 6 continents, including EuropeAsiaNorth America.

What is PARI's stock symbol?

PARI is a publicly traded company; the company's stock symbol is PABU.

What is PARI's official website and social media links?

PARI's official website is pari.com and has social profiles on LinkedIn.

What is PARI's NAICS code?

PARI's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does PARI have currently?

As of June 2026, PARI has approximately 426 employees across 6 continents, including EuropeAsiaNorth America. Key team members include Vp Sales Europe & Asia Pacific: G. B.President & Executive Officer, Pari Japan Gk: H. T.President Asia Pacific: W. P.. Explore PARI's employee directory with LeadIQ.

What industry does PARI belong to?

PARI operates in the Medical Equipment Manufacturing industry.

What technology does PARI use?

PARI's tech stack includes Adobe IllustratorGitHubPimcoreMicrosoft OutlookjQueryMicrosoft OfficeLinuxBootstrap.

What is PARI's email format?

PARI's email format typically follows the pattern of First.Last@pari.com. Find more PARI email formats with LeadIQ.

When was PARI founded?

PARI was founded in 1906.

PARI

Q: What is PARI's official website and social media links?

PARI's official website is pari.com. PARI has social profiles on LinkedIn.

Q: How many employees does PARI have currently?

PARI has approximately 426 employees.

Q: What technology does PARI use?

PARI's tech stack includes Video.js, Akeneo, Visual Studio Code, Adobe Acrobat DC, Select2.

Q: What is PARI's NAICS code?

PARI's NAICS code is 3391 (Medical Equipment and Supplies Manufacturing).

Medical Equipment ManufacturingBavaria, Germany201-500 Employees

PARI is a medical device manufacturer based in Starnberg, Bavaria, with a history dating to 1906 when it was founded in Wuppertal. Today, the group includes production operations in Weilheim (PARItec) and medicinal products and eFlow technology in Gräfelfing (PARI Pharma), supported by an international network of offices and distribution.

It focuses on respiratory therapy, serving doctors, pharmacists, and patients with devices and solutions for inhalation across pulmonary, bronchial, and nasopharyngeal diseases, including diagnosis, treatment, and monitoring. The company is described as the global market leader in nebuliser devices for cystic fibrosis and emphasizes continued development and broad services for users and medical professionals.